GENE ONLINE|News &
Opinion
Blog

Immuno-oncology
Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare
2022-11-29
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
F-star Therapeutics Signs On to invoX Pharma for $161 Million to Stay Afloat
2022-06-24
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Exscientia Signs $1 Billion Worth AI Deal to Boost BMS’ Drug Discovery Pipeline
2021-05-21
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
Embracing Artificial Intelligence and Machine Learning in Cancer Research and Care
2021-04-18
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
2021-01-15
Sanofi Looks to Bolster Immunology Pipeline By Acquiring Kymab for $1.5 Billion
2021-01-13
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
1 2
LATEST
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Amgen Faces Class Action Lawsuit for Concealing $10.7 Billion Tax Bill to Manipulate Stock Price
2023-03-16
ImmunoPrecise Antibodies, Libera Bio Ink $155 Million Pact To Deliver Antibodies With Nanotechnology
2023-03-16
Dermavant Eyes Second Vtama Indication with Topline Atopic Dermatitis Results
2023-03-15
Scroll to Top